Taipei Exchange - Delayed Quote TWD

Universal Vision Biotechnology Co., Ltd. (3218.TWO)

201.50
+18.00
+(9.81%)
At close: 1:30:36 PM GMT+8

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Zhenghong Lu General Manager 7.83M -- --
Mr. Pi-Jung Lin Founder, President, CTO & Representative Director 2.92M -- --
Yujiao Sun Director of Finance & Accounting -- -- --
Mr. Yu-chi Chan Director of Human Resources & Administration Division -- -- --
Mr. Chien-Hsiang Yu Director of Marketing Division -- -- --
Ms. Shu-Hsin Lin Chief Auditor of Audit Office -- -- --

Universal Vision Biotechnology Co., Ltd.

No.3-1 Yuanqu Street
4th Floor Nangang District
Taipei
Taiwan
886 2 2655 8000 https://www.uvb.com.tw/
Sector: 
Healthcare
Industry: 
Medical Devices

Description

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism. Furthermore, it offers eye plastic and micro cosmetic surgery; and aesthetic medicine consulting services, and provides nutritional supplements for eye protection. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.

Corporate Governance

Universal Vision Biotechnology Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 11, 2025 at 10:59 AM UTC - August 15, 2025 at 12:00 PM UTC

Universal Vision Biotechnology Co., Ltd. Earnings Date

Recent Events

March 26, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers